588 related articles for article (PubMed ID: 18804506)
1. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
Cenna J; Tan GS; Papaneri AB; Dietzschold B; Schnell MJ; McGettigan JP
Vaccine; 2008 Nov; 26(50):6405-14. PubMed ID: 18804506
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a single-cycle rabies virus-based vaccine vector.
Gomme EA; Faul EJ; Flomenberg P; McGettigan JP; Schnell MJ
J Virol; 2010 Mar; 84(6):2820-31. PubMed ID: 20053743
[TBL] [Abstract][Full Text] [Related]
3. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
[TBL] [Abstract][Full Text] [Related]
4. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.
Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z
Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451
[TBL] [Abstract][Full Text] [Related]
5. A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection.
Foley HD; McGettigan JP; Siler CA; Dietzschold B; Schnell MJ
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14680-5. PubMed ID: 11114165
[TBL] [Abstract][Full Text] [Related]
6. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.
Ge J; Wang X; Tao L; Wen Z; Feng N; Yang S; Xia X; Yang C; Chen H; Bu Z
J Virol; 2011 Aug; 85(16):8241-52. PubMed ID: 21632762
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice.
Faber M; Bette M; Preuss MA; Pulmanausahakul R; Rehnelt J; Schnell MJ; Dietzschold B; Weihe E
J Virol; 2005 Dec; 79(24):15405-16. PubMed ID: 16306612
[TBL] [Abstract][Full Text] [Related]
8. A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector.
Giel-Moloney M; Rumyantsev AA; David F; Figueiredo M; Feilmeier B; Mebatsion T; Parrington M; Kleanthous H; Pugachev KV
Vaccine; 2017 Dec; 35(49 Pt B):6898-6904. PubMed ID: 28899628
[TBL] [Abstract][Full Text] [Related]
9. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M
Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325
[TBL] [Abstract][Full Text] [Related]
10. Rabies-virus-glycoprotein-pseudotyped recombinant baculovirus vaccine confers complete protection against lethal rabies virus challenge in a mouse model.
Wu Q; Yu F; Xu J; Li Y; Chen H; Xiao S; Fu ZF; Fang L
Vet Microbiol; 2014 Jun; 171(1-2):93-101. PubMed ID: 24793501
[TBL] [Abstract][Full Text] [Related]
11. Parainfluenza virus 5 expressing the G protein of rabies virus protects mice after rabies virus infection.
Huang Y; Chen Z; Huang J; Fu Z; He B
J Virol; 2015 Mar; 89(6):3427-9. PubMed ID: 25552723
[TBL] [Abstract][Full Text] [Related]
12. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
[TBL] [Abstract][Full Text] [Related]
13. An inactivated recombinant rabies CVS-11 virus expressing two copies of the glycoprotein elicits a higher level of neutralizing antibodies and provides better protection in mice.
Xue XH; Zheng XX; Wang HL; Ma JZ; Li L; Gai WW; Wang TC; Yang ST; Xia XZ
Virus Genes; 2014 Jun; 48(3):411-20. PubMed ID: 24535572
[TBL] [Abstract][Full Text] [Related]
14. Rabies virus glycoprotein and immune response pattern using recombinant protein or recombinant RNA viral vectors.
Astray RM; Ventini DC; Boldorini VL; Silva FG; Rocca MP; Pereira CA
Vaccine; 2014 May; 32(24):2829-32. PubMed ID: 24598721
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.
Xiang ZQ; Spitalnik S; Tran M; Wunner WH; Cheng J; Ertl HC
Virology; 1994 Feb; 199(1):132-40. PubMed ID: 8116236
[TBL] [Abstract][Full Text] [Related]
16. DNA vaccine for rabies: relevance of the trans-membrane domain of the glycoprotein in generating an antibody response.
Rath A; Choudhury S; Batra D; Kapre SV; Rupprecht CE; Gupta SK
Virus Res; 2005 Nov; 113(2):143-52. PubMed ID: 15978691
[TBL] [Abstract][Full Text] [Related]
17. Negative effects of a disulfide bond mismatch in anti-rabies G protein single-chain antibody variable fragment FV57.
Duan Y; Gu T; Zhang X; Jiang C; Yuan R; Li Z; Wang D; Chen X; Wu C; Chen Y; Wu Y; Kong W
Mol Immunol; 2014 Jun; 59(2):136-41. PubMed ID: 24598312
[TBL] [Abstract][Full Text] [Related]
18. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
[TBL] [Abstract][Full Text] [Related]
19. Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic.
McGettigan JP; Pomerantz RJ; Siler CA; McKenna PM; Foley HD; Dietzschold B; Schnell MJ
J Virol; 2003 Jan; 77(1):237-44. PubMed ID: 12477829
[TBL] [Abstract][Full Text] [Related]
20. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice.
Tian L; Yan L; Zheng W; Lei X; Fu Q; Xue X; Wang X; Xia X; Zheng X
Vet Microbiol; 2021 Jun; 257():109076. PubMed ID: 33957572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
